Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06295-4Source: DataRank Database

NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells is a research paper published in Breast Cancer Research and Treatment (2021). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.68)OA: greenTopics (61)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Steven Elliott ORCID,ThiHongNgoc Hoang,Hope E. Burks ORCID,Maryl Wright,Madlin Alzoubi

Live enrichment

PubMed:34196902 OpenAlex:https://openalex.org/W3163142692

National Center for Advancing Translational Sciences

Grant: 1R03TR003386-01

Characterization of an understudied kinase, NEK5, in acquisition of a mesenchymaland migratory cell phenotype

National Institutes of Health

Grant: R01-CA174785-01A1

National Cancer Institute

Grant: R01CA125806

NCATS NIH HHS

Grant: R03 TR003386

Wellcome Trust

Grant: 106169/Z/14/Z

National Institutes of Health

Grant: 5R01CA174785-04

Kinase mediated suppression of metastasis in breast cancer

Wellcome Trust

Grant: 106169

A UK Hub to Catalyse Open Target Discovery.

National Institutes of Health

Grant: 5R01CA125806-05

MEK5-Erk5 in breast cancer resistance

FWCI

1.68

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

greenLicense: cc-by

repositoryhttps://scholarworks.indianapolis.iu.edu/bitstreams/ed8ca458-a474-4bf1-935e-af2b9bfa6dd3/download

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-021-06295-4.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-021-06295-4/fulltext.html

repositoryhttps://hdl.handle.net/1805/31783

Fields of Study

Microtubule and mitosis dynamicsMelanoma and MAPK PathwaysCancer Cells and Metastasis0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsBreast NeoplasmsCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionFemaleHumansMiceNIMA-Related KinasesPhenotypeRNA, Small Interfering

MeSH Terms

NIMA-Related KinasesAnimalsBreast NeoplasmsCell MovementFemaleHumansPhenotypeRNA, Small InterferingCell Line, TumorCell ProliferationMiceEpithelial-Mesenchymal Transition

Keywords

Cancer researchKinomeMetastasisMetastatic breast cancerBiologyCell migrationCell growthBreast cancerCancerCancer cellGene knockdownCellCell biologyKinaseCell cultureCell motilityMesenchymal PhenotypeKinase TargetNever-in-mitosis A-related KinaseEpithelial-Mesenchymal TransitionBreast NeoplasmsMicePhenotypeCell MovementCell Line, TumorAnimalsHumansNIMA-Related KinasesFemaleRNA, Small InterferingCell Proliferation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being